Artificial intelligence for antiviral drug discovery in low resourced settings: A perspective
Open Access
- 2 November 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Drug Discovery
- Vol. 2
Abstract
Current antiviral drug discovery efforts face many challenges, including development of new drugs during an outbreak and coping with drug resistance due to rapidly accumulating viral mutations. Emerging artificial intelligence and machine learning (AI/ML) methods can accelerate anti-infective drug discovery and have the potential to reduce overall development costs in Low and Middle-Income Countries (LMIC), which in turn may help to develop new and/or accessible therapies against communicable diseases within these countries. While the marketplace currently offers a plethora of data-driven AI/ML tools, most to date have been developed within the context of non-communicable diseases like cancer, and several barriers have limited the translation of existing tools to the discovery of drugs against infectious diseases. Here, we provide a perspective on the benefits, limitations, and pitfalls of AI/ML tools in the discovery of novel therapeutics with a focus on antivirals. We also discuss available and emerging data sharing models including intellectual property-preserving AI/ML. In addition, we review available data sources and platforms and provide examples for low-cost and accessible screening methods and other virus-based bioassays suitable for implementation of AI/ML-based programs in LMICs. Finally, we introduce an emerging AI/ML-based Center in Cameroon (Central Africa) which is currently developing methods and tools to promote local, independent drug discovery and represents a model that could be replicated among LMIC globally.Keywords
Funding Information
- Bill and Melinda Gates Foundation (INV-036848)
This publication has 114 references indexed in Scilit:
- NPACT: Naturally Occurring Plant-based Anti-cancer Compound-Activity-Target databaseNucleic Acids Research, 2012
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012
- Towards a gold standard: regarding quality in public domain chemistry databases and approaches to improving the situationDrug Discovery Today, 2012
- Principles of early drug discoveryBritish Journal of Pharmacology, 2011
- TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In SilicoPLOS ONE, 2011
- Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling ResearchJournal of Chemical Information and Modeling, 2010
- BIAdb: A curated database of benzylisoquinoline alkaloidsBMC Pharmacology, 2010
- Pathway databases and tools for their exploitation: benefits, current limitations and challengesMolecular Systems Biology, 2009
- Rationale and Uses of a Public HIV Drug‐Resistance DatabaseThe Journal of Infectious Diseases, 2006
- Molecular Cloning and Biological Characterization of Full-Length HIV-1 Subtype C from BotswanaVirology, 2000